Israel
· Delayed Price · Currency is ILS · Price in ILA OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of ILS 3.43 billion. The enterprise value is 3.72 billion.
| Market Cap | 3.43B |
| Enterprise Value | 3.72B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -7.68% |
| Shares Change (QoQ) | -4.66% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 253.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.32 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 38.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.17 |
| EV / Sales | 1.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.89 |
Financial Position
The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.37.
| Current Ratio | 3.43 |
| Quick Ratio | 2.87 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.42 |
| Interest Coverage | -5.76 |
Financial Efficiency
Return on equity (ROE) is -3.86% and return on invested capital (ROIC) is -9.54%.
| Return on Equity (ROE) | -3.86% |
| Return on Assets (ROA) | -8.12% |
| Return on Invested Capital (ROIC) | -9.54% |
| Return on Capital Employed (ROCE) | -13.63% |
| Revenue Per Employee | 866,692 |
| Profits Per Employee | -64,684 |
| Employee Count | 2,997 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 8.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.66% in the last 52 weeks. The beta is 1.79, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +10.66% |
| 50-Day Moving Average | 605.88 |
| 200-Day Moving Average | 576.20 |
| Relative Strength Index (RSI) | 33.54 |
| Average Volume (20 Days) | 284,555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.92 |
Income Statement
In the last 12 months, OPKO Health had revenue of ILS 2.60 billion and -193.86 million in losses. Loss per share was -0.28.
| Revenue | 2.60B |
| Gross Profit | 412.66M |
| Operating Income | -996.38M |
| Pretax Income | -37.81M |
| Net Income | -193.86M |
| EBITDA | -638.79M |
| EBIT | -996.38M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 1.55 billion in cash and 1.84 billion in debt, giving a net cash position of -283.60 million.
| Cash & Cash Equivalents | 1.55B |
| Total Debt | 1.84B |
| Net Cash | -283.60M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.97B |
| Book Value Per Share | 7.41 |
| Working Capital | 1.71B |
Cash Flow
In the last 12 months, operating cash flow was -668.32 million and capital expenditures -91.09 million, giving a free cash flow of -759.42 million.
| Operating Cash Flow | -668.32M |
| Capital Expenditures | -91.09M |
| Free Cash Flow | -759.42M |
| FCF Per Share | n/a |
Margins
Gross margin is 15.89%, with operating and profit margins of -38.36% and -7.46%.
| Gross Margin | 15.89% |
| Operating Margin | -38.36% |
| Pretax Margin | -1.46% |
| Profit Margin | -7.46% |
| EBITDA Margin | -24.59% |
| EBIT Margin | -38.36% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.68% |
| Shareholder Yield | 7.68% |
| Earnings Yield | -5.64% |
| FCF Yield | -22.11% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.48. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.48 |
| Piotroski F-Score | n/a |